Telsey Advisory Group analyst Dana Telsey maintains Dillard’s (NYSE:DDS) with a Market Perform and raises the price target from $350 to $380.
Telsey Advisory Group Maintains Market Perform on Dillard’s, Raises Price Target to $380
Telsey Advisory Group analyst Dana Telsey maintains Dillard's (NYSE:DDS) with a Market Perform and raises the price target from $350 to $380.
Related Posts
Allogene’s BCMA-Targeted Therapy Gets US Orphan Drug Tag For Multiple Myeloma
The FDA has granted Orphan Drug Designation to Allogene Therapeutics Inc’s (NASDAQ:ALLO) ALLO-715 to treat multiple myeloma. In April 2021, ALLO-715 received…
Recap: Epizyme Q2 Earnings
Shares of Epizyme (NASDAQ:EPZM) moved higher by 13.3% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 8.62% year over year to ($0.63), which missed the estimate of ($0.62).